KeyBanc Capital Markets has recently initiated Humana Inc (HUM) stock to Sector Weight rating, as announced on October 11, 2024, according to Finviz. Earlier, on October 8, 2024, Bernstein had raised the stock from a Mkt Perform to Outperform, setting a price target of $308. TD Cowen also reduced Hold rating with a price target of $261. Additionally, Jefferies reduced Hold rating on October 7, 2024, with a target price of $253. Piper Sandler analysts, in their report published on October 3, 2024, also reduced Neutral rating and set a price target of $274 for Humana Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Humana Inc (HUM) Stock Trading Recap
On Monday, Humana Inc (HUM) stock saw a decline, ending the day at $255.55 which represents a decrease of $-5.16 or -1.98% from the prior close of $260.71. The stock opened at $260.9 and touched a low of $251.83 during the day, reaching a high of $262.09. The volume of shares traded was 1.91 million falling short of the average volume of 2.09 million.
Sponsored
HUM Stock Performance and Moving Averages
In recent trading, Humana Inc (HUM) stock price has shown some volatility, fluctuating -2.12% over the last five trades and 6.47% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -19.95%, and it has plunged by -28.06% in the previous three months. Currently, HUM is trading at -1.19%, -13.40%, and -24.57% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, HUM, a Healthcare sector stock, is trading -51.53% below its 52-week high but remains 19.80% above its 52-week low. The Average True Range (ATR) (14 days) of 10.8 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Humana Inc’s Profitability and Valuation Ratios
Humana Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 2.40% and a profit margin of 1.18%, with a gross margin of -19.95%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Humana Inc’s market capitalization stands at $31.11 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The stock’s price-to-earnings (P/E) ratio is 22.63, assessing the company’s valuation relative to its earnings. The forward P/E ratio, which uses projected earnings for the next financial year, is 14.5. Additionally, the Price-to-Sales Ratio is 0.27, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 1.75, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.25% of Humana Inc (HUM)’s shares, while financial institutions hold 95.65%.